Biggest News Aggregation in the World
📰 Nasdaq Pcvx News

Page 5 - Nasdaq Pcvx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Pcvx. Real-time updates on events, politics, business and more.

Head-To-Head Contrast: REGENXBIO (NASDAQ:RGNX) versus Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Get Rating) and REGENXBIO (NASDAQ:RGNX – Get Rating) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Vaxcyte and REGENXBIO’s net margins, return on equity […]
United States San Carlos Jamesm Wilson Regenxbio Inc Vaxcyte Inc Technology Platform

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Brokerages

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) has been given an average recommendation of “Buy” by the eight brokerages that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have covered the stock in the last year is […]
United States Metlife Investment Management Vaxcyte Inc York Mellon Corp Jpmorgan Chase Co Swiss National Bank

Opaleye Management Inc. Trims Position in Vaxcyte, Inc. (NASDAQ:PCVX)

Opaleye Management Inc. reduced its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) by 6.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 177,000 shares of the company’s stock after selling 13,000 shares during the period. Vaxcyte makes up 3.0% of Opaleye Management […]
United States Zurcher Kantonalbank Zurich Cantonalbank Great West Life Assurance Co China Universal Asset Management Co Vaxcyte Inc Allspring Global Investments Holdings

Tekla Capital Management LLC Makes New $240,000 Investment in Vaxcyte, Inc. (NASDAQ:PCVX)

Tekla Capital Management LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 5,000 shares of the company’s stock, valued at approximately $240,000. Other large investors also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC […]
United States Ghost Tree Capital Needham Company Tekla Capital Management Vaxcyte Inc Swiss National Bank

Sectoral Asset Management Inc. Purchases New Stake in Vaxcyte, Inc. (NASDAQ:PCVX)

Sectoral Asset Management Inc. purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 60,000 shares of the company’s stock, valued at approximately $2,877,000. Sectoral Asset Management Inc. owned about 0.08% […]
United States Zurcher Kantonalbank Zurich Cantonalbank Sectoral Asset Management Inc China Universal Asset Management Co Needham Company Vaxcyte Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analysts

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) have been given an average recommendation of “Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued ratings on the stock in the […]
United States Carlyle Group Inc Jennison Associates Needham Company Vaxcyte Inc Vaxcyte Company Profile

888 Reaffirms "Reiterates" Rating for Vaxcyte (NASDAQ:PCVX)

888 reiterated their reiterates rating on shares of Vaxcyte (NASDAQ:PCVX – Get Rating) in a report published on Tuesday morning, Benzinga reports. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued a buy rating and set a $58.00 price target on shares of Vaxcyte in a research note […]
United States Needham Company Carlyle Group Inc Vaxcyte Inc Jennison Associates Get Rating

FY2023 EPS Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) Lifted by Cantor Fitzgerald

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) – Equities researchers at Cantor Fitzgerald boosted their FY2023 EPS estimates for shares of Vaxcyte in a report issued on Tuesday, May 9th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($3.15) per share for the year, up from their prior estimate of ($3.93). The […]
United States Cantor Fitzgerald Needham Company Envestnet Asset Management Inc Vaxcyte Inc Profund Advisors

Vaxcyte (NASDAQ:PCVX) Given Reiterates Rating at 888

Vaxcyte (NASDAQ:PCVX – Get Rating)‘s stock had its “reiterates” rating restated by analysts at 888 in a report issued on Tuesday, Benzinga reports. A number of other equities research analysts have also issued reports on PCVX. Bank of America upped their target price on Vaxcyte from $63.00 to $68.00 in a research note on Monday, […]
United States Needham Company Prudential Financial Inc China Universal Asset Management Co Vaxcyte Inc Vaxcyte Company Profile
Source: wkrb13.com

Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Buy" from Brokerages

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) has been assigned an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the stock in the last […]
United States Vanguard Group Inc Blackrock Inc Vaxcyte Inc Carlyle Group Inc Vaxcyte Company Profile

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science